112 related articles for article (PubMed ID: 36484308)
1. Lymph-node metastasis from gastric adenocarcinoma in a patient bearing a germ line missense variant MSH2 c.1808A > T (Asp603Val) responds to the immune checkpoint inhibitor pembrolizumab.
Kiyomiya M; Fukuda K; Shimazu K; Yoshida T; Taguchi D; Shinozaki H; Nanjyo H; Shibata H
Jpn J Clin Oncol; 2023 Mar; 53(3):270-274. PubMed ID: 36484308
[TBL] [Abstract][Full Text] [Related]
2. A novel Lynch syndrome pedigree bearing germ-line MSH2 missense mutation c.1808A>T (Asp603Val).
Sekine R; Shimazu K; Nakano D; Yamaguchi T; Suzuki Y; Fukuda K; Yoshida T; Taguchi D; Iijima K; Nanjyo H; Shibata H
Jpn J Clin Oncol; 2022 Jan; 52(1):81-85. PubMed ID: 34761252
[TBL] [Abstract][Full Text] [Related]
3. Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation.
Xu Y; Li Q; Zhao J; Ni X; Li P; Hu W
Front Immunol; 2022; 13():1064488. PubMed ID: 36518767
[TBL] [Abstract][Full Text] [Related]
4. A Rare
Kabbage M; Ben Aissa-Haj J; Othman H; Jaballah-Gabteni A; Laarayedh S; Elouej S; Medhioub M; Kettiti HT; Khsiba A; Mahmoudi M; BelFekih H; Maaloul A; Touinsi H; Hamzaoui L; Chelbi E; Abdelhak S; Boubaker MS; Azzouz MM
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011265
[TBL] [Abstract][Full Text] [Related]
5. A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation.
T Danley K; Schmitz K; Ghai R; Sclamberg JS; Buckingham LE; Burgess K; Kuzel TM; Usha L
Oncologist; 2021 Oct; 26(10):811-817. PubMed ID: 34018286
[TBL] [Abstract][Full Text] [Related]
6. A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay.
Bianchi F; Maccaroni E; Belvederesi L; Brugiati C; Giampieri R; Bini F; Bracci R; Pagliaretta S; Del Prete M; Piva F; Mandolesi A; Scarpelli M; Berardi R
Fam Cancer; 2018 Apr; 17(2):215-224. PubMed ID: 28785832
[TBL] [Abstract][Full Text] [Related]
7. Pathogenicity of A600V variant in exon 12 of the MSH2 gene detected in a Japanese kindred with Lynch syndrome.
Miyakura Y; Sugano K; Nomizu T; Lefor A; Yasuda Y
Jpn J Clin Oncol; 2012 Jan; 42(1):78-82. PubMed ID: 22086974
[TBL] [Abstract][Full Text] [Related]
8. A novel missense MSH2 gene mutation in a patient of a Korean family with hereditary nonpolyposis colorectal cancer.
Park SJ; Lee KA; Park TS; Kim NK; Song J; Kim BY; Choi JR
Cancer Genet Cytogenet; 2008 Apr; 182(2):136-9. PubMed ID: 18406877
[TBL] [Abstract][Full Text] [Related]
9. Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome.
Gargiulo S; Torrini M; Ollila S; Nasti S; Pastorino L; Cusano R; Bonelli L; Battistuzzi L; Mastracci L; Bruno W; Savarino V; Sciallero S; Borgonovo G; Nyström M; Bianchi-Scarrà G; Mareni C; Ghiorzo P
Fam Cancer; 2009; 8(4):547-53. PubMed ID: 19728162
[TBL] [Abstract][Full Text] [Related]
10. MSH2 c.1022T>C, p.Leu341Pro is a founder pathogenic variation and a major cause of Lynch syndrome in the North of France.
Vermaut C; Leclerc J; Vasseur F; Wacrenier A; Lovecchio T; Boidin D; Rebergue MH; Cattan S; Manouvrier S; Lejeune S; Buisine MP
Genes Chromosomes Cancer; 2020 Feb; 59(2):111-118. PubMed ID: 31433521
[TBL] [Abstract][Full Text] [Related]
11. A new mutL homolog 1 c.1896+5G>A germline mutation detected in a Lynch syndrome-associated lung and gastric double primary cancer patient.
Chen X; Li X; Liang H; Wei L; Cui Q; Yao M; Wu X
Mol Genet Genomic Med; 2019 Aug; 7(8):e787. PubMed ID: 31207149
[TBL] [Abstract][Full Text] [Related]
12. A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy.
Bianchi F; Galizia E; Porfiri E; Belvederesi L; Catalani R; Loretelli C; Bracci R; Bearzi I; Turchi C; Viel A; Cellerino R
Fam Cancer; 2007; 6(1):97-102. PubMed ID: 17165155
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer in a 9-year-old due to combined EPCAM and MSH2 germline mutations: case report of a unique genotype and immunophenotype.
Li-Chang HH; Driman DK; Levin H; Siu VM; Scanlan NL; Buckley K; Cairney AE; Ainsworth PJ
J Clin Pathol; 2013 Jul; 66(7):631-3. PubMed ID: 23454724
[No Abstract] [Full Text] [Related]
14. Novel MSH2 splice-site mutation in a young patient with Lynch syndrome.
Liccardo R; De Rosa M; Izzo P; Duraturo F
Mol Med Rep; 2018 May; 17(5):6942-6946. PubMed ID: 29568967
[TBL] [Abstract][Full Text] [Related]
15. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.
Ponti G; Manfredini M; Tomasi A; Pellacani G
Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115
[TBL] [Abstract][Full Text] [Related]
16. Durable benefit from immunotherapy and accompanied lupus erythematosus in pancreatic adenocarcinoma with DNA repair deficiency.
Pang X; Qian J; Jin H; Zhang L; Lin L; Wang Y; Lei Y; Zhou Z; Li M; Zhang H
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32636238
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cancer and a novel MSH2 germline alteration.
Lindor NM; Petersen GM; Spurdle AB; Thompson B; Goldgar DE; Thibodeau SN
Pancreas; 2011 Oct; 40(7):1138-40. PubMed ID: 21926548
[TBL] [Abstract][Full Text] [Related]
18. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M
Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783
[TBL] [Abstract][Full Text] [Related]
19. A radiological complete response to pembrolizumab in a patient with metastatic upper urinary tract urothelial cancer and Lynch syndrome.
Oki R; Urasaki T; Ueki A; Inamura K; Komai Y; Takahashi S; Yonese J; Yuasa T
IJU Case Rep; 2023 Jan; 6(1):33-36. PubMed ID: 36605683
[TBL] [Abstract][Full Text] [Related]
20. Sporadic endometrial adenocarcinoma with MMR deficiency due to biallelic MSH2 somatic mutations.
Buecher B; De Pauw A; Bazire L; Houdayer C; Fievet A; Moncoutier V; Farkhondeh F; Melaabi S; Lyonnet DS; Golmard L
Fam Cancer; 2018 Apr; 17(2):281-285. PubMed ID: 28819700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
